The Series A round, which included participation from North Island Ventures and existing investors, brings New York-based Mural's total funding to $28 million.
OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research.
Enterprises are deploying AI agents on top of incomplete and siloed workforce data that sit scattered across HR and finance systems and a decade of point solutions, each with its own definitions and blind spots.
Some of the most interesting moments in music production come when an arrangement won’t work. The groove is there and the melody is promising, but something
Learned navigation policies typically consume observations as a temporally ordered history, with positional encodings tying each observation to when it was seen, making it difficult to reuse experience from earlier traversals of an environment. Systems that do reuse such…
Modeling protein-protein interactions requires accurate scoring functions that can rank potential poses (conformations) of a protein-protein complex to differentiate near-native poses from incorrect ones. Here, we propose a general framework for improving protein-protein pose…
Self-play methods that co-train a single language model as both coder and test author promise to move code-generation RL beyond fixed test suites, but they suffer from two coupled pathologies: permissiveness collapse, where pass-rate rewards are maximised by trivial,…
Procedural anomaly detection in bimanual assembly requires judging each hand action against the execution so far. A corrective action may look unusual in isolation, while a visually plausible action can violate the order of the procedure. We present HACT, a transition model…